TISSUE FACTOR Archives

Published on May 2003

The interaction between platelets and factor VII/VIIa.

Lau HKF

Transfus Apheresis Sci 2003;28(3):279-283.

Review by Aldouri M

Published on Dec 2002

Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.

Allen GA, Hoffman M, Roberts HR, Monroe DM

Can J Anaesth 2002;49(10):S7-S14.

Review by Aldouri M

Published on Dec 2002

Possible role of recombinant activated factor VII (RFVIIa) in the control of hemorrhage associated with massive trauma.

Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E

Can J Anaesth 2002;49(10):S15-S20.

Review by

Published on Dec 2002

Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.

Potapov EV, Pasic M, Bauer M, Hetzer R

Ann Thorac Surg 2002;74(6):2182-2183.

Review by Aldouri M

Published on Mar 2002

Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.

Toor AA, Slungaard A, Hedner U, Weisdorf DJ, Key NS

Bone Marrow Transplant 2002;29(5):403-408.

Review by Aldouri M

Published on Mar 2002

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.

Gerotziafas GT, Zervas C, Gavrielidis G, et al.

Am J Hematol 2002;69(3):219-222.

Review by M. Aldouri

Published on Mar 2002

Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.

Lisman T, Leebeek FWG, Meijer K, Van Der Meer J, Nieuwenhuis HK, De Groot PG

Hepatology 2002;35(3):616-621.

Review by

Published on Jan 2002

Potential role for rFVIIa in transfusion medicine.

Hedner U, Erhardtsen E

Transfusion 2002;42(1):114-124.

Review by Aldouri M

Published on Jan 2002

Inhibition of fibrinolysis by recombinant factor VIIA in plasma from patients with severe hemophilia A.

Lisman T, Mosnier LO, Lambert T, et al.

Blood 2002;99(1):175-179.

Review by

The interaction between platelets and factor VII/VIIa.

Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.

Possible role of recombinant activated factor VII (RFVIIa) in the control of hemorrhage associated with massive trauma.

Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.

Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.

Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.

Potential role for rFVIIa in transfusion medicine.

Inhibition of fibrinolysis by recombinant factor VIIA in plasma from patients with severe hemophilia A.

Sitemap

Contact us

Follow us

SUBSCRIBE TO OUR NEWSLETTER